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ABSTRACT
EDGAR DAVID URIBE SANCHEZ: Isolation of Sphingolipids from Sphingomonas echinoides
B-3126 and their Characterization by MS/MS Analysis
Sphingolipids are important components in human cellular lipid membranes and are
differentiated by the incorporation of serine with an amide bond between the amino acid and a
lipid tail. Sphingolipids produced by bacteria differ in both headgroups attached to the serine
alcohol and the architecture of the lipid backbone. While the synthesis of sphingolipids in
mammalian cells is well studied, only a handful of steps in the pathway are described in bacteria.
1

The observations that although sphingolipid synthesis is rare in bacteria, it is more common

among gut anaerobes and that these sphingolipids are substrates for CD1 signaling in the
immune system, suggest that sphingolipids are involved in immune regulation of the host by the
gut microbiome. In previous research on a mouse model, Bacteroides fragilis sphingolipids
showed an ability to signal the neonatal immune system, inducing smaller levels of the gut
invariant natural killer T (iNKT) cells in the adult and affording protection from colitis. 2 In my
project, the hypothesized role of sphingolipids participating in the immune signaling is the
motivation to isolate these compounds so they can serve as substrates to synthesize new immunestimulating/regulating compounds. When binding to CD1d, the lipid part of the sphingolipids
tends to control protein binding. The headgroup however is on the surface of the protein-lipid
complex, aiding in recognition of the T cell antigen receptor3 Previous research has been

reported in the development of headgroups that can selectively stimulate distinct cytokine
profiles from iNKT cells.4 The sphingolipids are effective substrates of human CD1d and prompt
the release of cytokines from activated iNKT cells. In this project, I conducted several
experiments to optimize sphingolipid production and characterize sphingolipids from the strain
Sphingomonas echinoides B-3126. I compared media for growing strains based on sphingolipid
yield, as well as attempting to increase yield with a salinity stressor. I worked to develop
sphingolipid extraction and isolation conditions. Following sphingolipid extraction, I used
LCMS screening analysis to compare the strains against known sphingolipids uploaded to the
Global Natural Products Social Molecular Networking (GNPS) platform. 5The goal of this
research project is to optimize the isolation of bacterial sphingolipids. In the future our lab could
functionalize these molecules into novel chemical entities, aiming for a large panel of semisynthetic sphingolipids that can be tested for triggering specific cytokine profiles or for function
as vaccine adjuvants.6

INTRODUCTION
Sphingolipids are involved in immune signaling and regulation via the CD1 signaling
pathway1 Bacteroides, a genus of Gram-negative, obligate anaerobic bacteria, and close relatives
make up over 50 percent of the gut microbiome and are differentiated from most other genera of
Gram-negative anaerobic bacteria by the fact that they produce sphingolipids 2 Sphingolipids are
responsible for modulating a variety of pathways including apoptosis, cell differentiation and
proliferation 7 In previous research on B. fragilis, it was found that this gut bacterium produced
an isoform of α-galactosylceramide 2 Originally isolated from a sponge, this sphingolipid is a
ligand for the immune receptor CD1d. The lipid portion of the sphingolipid from previous work
has been shown to control protein binding 7 The headgroup on the other hand has been shown to
be on the surface of the complex for the recognition of the T cell antigen receptor. The chemical
modification of these headgroups could possibly stimulate distinct cytokine responses, with a
wide range of potential therapeutic applications, such as function as vaccine adjuvants 6 In this
project, the aims were to first isolate the sphingolipids from a strain of Sphingomonas, a soil
bacterium that is within the other major clade of sphingolipid producing bacteria 2 then
characterize these sphingolipids by LCMS analysis. Various forms of extraction and sphingolipid
isolation, such as phase separation, were used followed by LCMS characterization and analysis
on the GNPS platform. Following this analysis of the extracted sphingolipids we used the results
of the LCMS to compare these sphingolipids to the reported structures in the GNPS platform.

This thesis focuses on developing methods for the isolation of sphingolipids from our bacteria
with the larger goal of creating a panel of sphingolipids and that might be used directly, or semisynthetically modified, to target the immune signaling property of sphingolipids as potential
therapeutic tools.

Role of Sphingolipids in the Human Gut Microbiota
Bacteroides are known to be one of the most abundant genus in the human intestinal
microbiome, where average human gut contains over one trillion bacterial cells from this type of
bacteria. 7 Sphingolipids are aliphatic amnio alcohols which are present in the make-up of some
prokaryotic and all eukaryotic cell membranes. 8 Sphingolipids are signaling molecules with
specialized roles in regulating immunity, inflammation, autophagy, and survival. In earlier
studies sphingolipids were identified in being involved with autoimmune and inflammatory
diseases such as Inflammatory Bowel Disease (IBD). 7 Along with immune signaling,
sphingolipids are found to be crucial in gut homeostasis and symbiosis. In an earlier study
working to find the correlation between bacterial sphingolipid deficiency and IBD, it was found
that there was a negative correlation between sphingolipid production in the microbiome and
inflammation 7 There was also a lower abundance of sphingolipids in the IBD metabolomic
dataset.

Sphingolipid synthesis is dependent on an enzyme called serine palmitoyltransferase
(SPT), which catalyzes the reaction between serine and an acyl-CoA thioester to form 3ketosphinganine.9 Analyzing this pathway, a previous research study investigated a known wildtype strain of B. fragilis and a mutant lacking the SPT gene (which could therefore not make
sphingolipids), finding three lipid structures present in the wild-type and absent from the mutant.

These lipid structures were identified as the sphingolipid ceramide phosphoryl ethanolamine, and
its corresponding dihydroceramide base. The third compound was the glycosphingolipid agalactosylcermide. 2

MATERIALS AND METHODS
Preparation of Media:
First, we isolated the sphingolipids from a strain of Sphingomonas echinoides, a soil bacterium
that is within the other major clade of sphingolipid producing bacteria, to complete this
experimentation I needed to create media to culture the cells, and then harvest them for
extraction.2 We created NRRL-1 media, LB media, Brain Heart Infusion (BHI) media, and the
PYG media to determine which media would be best for growth of B-3126. To create the NRRL1 medium we used the following protocol: Per Liter of medium- 5.0g Tryptone, 5.0g Yeast
extract, 1.0g K2HPO4, Glucose 1.0g, and 15.0g Agar. We then adjusted the pH to 7.0 before
autoclaving. The LB media was premised from Sigma-Aldrich and the components included 5
g/L NaCl, 10 g/L Tryptone, and 5 g/L Yeast extract.

Optimal Media Test:
We used the NRRL-1 media, LB media, Brain Heart Infusion (BHI) media, and the PYG media
to determine which media would be best for growth of B-3126. In 15 mL test tubes we aliquoted
separately 5 mL from each medium under sterile conditions. We inoculated ca. 1 µL of B-3126
using a blue loop into each medium. We then put these four test tubes into the incubator at 37
degrees Celsius and waited for a turbid culture to form. After turbidity was observed we

harvested the cells and conducted a small-scale extraction of sphingolipid material. The extracts
were then submitted to LCMS analysis to compare sphingolipid profiles from the organism
across culture media.

Salinity Stressor Test:
Using aerobic growth of B-3126, we challenged the organism with a stressor, specifically
salinity. The stressor was used to try and induce more sphingolipid production through osmotic
stress that might change the lipid content in the cell membrane. I prepared 500 mL of liquid
NRRL-1 medium. I then split the media into 5 x 100 mL portions and put them in 250 mL
Erlenmeyer flasks. I then added NaCl to these flasks: 4.0 g, 2.0 g, 1.0 g, 0.5 g, and 0 g (no added
salt) and labeled them. After that I covered the flasks with aluminum foil and sterilized them in
the autoclave with a 15 min liquids cycle. I then streaked out B-3126 from the frozen stock
prepared on an NRRL-1 agar plate. I then let it grow at 28 °C in the incubator for about 48 hours.
I then used a colony from the plate to inoculate 5 mL of sterile NRRL-1 medium (with no added
salt), I then let the sample grow shaking at 28 °C in the incubator for 48 hours. I then measured
out 3 x 5 mL of each of each salt concentration medium into culture tubes. I then inoculated this
media with 5.0 µL of the turbid normal salinity starter culture. I then grew them again for 48 h in
the incubator. I then extracted the lipids using the same extraction method as the media
optimization experiment and ran them on the LCMS.

Sphingolipid Extraction:

We created a 0.2 M solution of NaOH in MeOH (100mL), I put 0.8 g of NaOH in a bottle and
added 100 mL of MeOH, I then placed a stir bar and mixed for 15 minutes. I then removed the
sphingolipid extract from the fridge. I used the 0.2 M of NaOH in MeOH solution to treat the
sphingolipid extract, after adding the base solution I stirred the mixture vigorously, mixing the
solution by hand to prevent lipids clinging to the side of the flask. Once the basic solution had
fully suspended the lipid extract, I placed the sample in a smaller flask to heat. I then placed a
stir bar in the smaller flask and placed the flask in a sand bath with a thermometer. We heated the
sample up to 37 degrees Celsius for 30 minutes to break the glycerol-fatty acid ester linkages of
all the non-sphingolipids lipids. I continually monitored the temperature to stop the sample from
overheating. After heating I placed the sample in the rotovap to evaporate the solvent. Once the
sample was dry, I placed the flask in the refrigerator.

I took my dried sphingolipid extraction out of the fridge and washed it with 50 mL of
chloroform. I then built a separation funnel apparatus to separate by polarity. I poured 50 mL
MeOH, 50 mL brine, and 50 mL of MiliQ in the separatory funnel to form the layers. I then
added an additional 50 mL of chloroform with the washed sphingolipid sample to create milklike emulsion. I opened the stop cock under the hood and collected the organic layer. I did this 3
times with shaking the funnel in between each separation. This resulted in the final separation of
chloroform/methanol and sphingolipid mixture (the nonpolar fraction). I then used the rotovap to
dry out the sample and then I put it in the refrigerator.

I took my sample out of refrigerator and took some 2:1 chloroform and methanol solution with a
pipette and dissolved some of the sample. I then used the pipette to transfer about 3 drops of the
dissolved sample in a small vial (4.753 g) by running it through the C-18 column. Column C-18

100mL specs: 90% H20, MeOH 100mL (column). I then put this small sample on the rotovap
for 10 minutes using a small adaptor. I created a total 2 samples vials through the column one
vial concentrated with 5mg and one diluted. We then ran the two samples in the LCMS to see if
the diluted or concentrated sample would be more optimal to use.

Sphingolipid Silica Plate Large/Small Scale:

First, I prepared a 65:20:10 ratio of chloroform and acetic acid and methanol in a 100 mL
graduated cylinder. We then used silica plates to take up some of our sample B-3126. Then we
used the solvent we used and let it travel up the strips of silica plate, with filter paper in the
vessel to minimize the role of evaporation. Once this was done, we dipped the 65:25:10 TLC in
permanganate stain. Then we used a heat gun to dry the sample, we then observed the separation
of spots and Rf values of separation. Rf values are as follows: (total length 3.5 cm) first spot
0.29, second spot 0.63. Total grams of final sample 0.0585 g.

For the large scale first, I prepared a 65:25:10 Chloroform/Methanol/Acetic acid solvent mixture
with a total volume of 200 mL. Following this we put the solvent in a preparative TLC chamber,
about 2.5 cm above the bottom. We then used a large silica plate (silica gel G) and filter paper
and placed them in the solvent. Before placing the silica plate in the solvent, we added a line of
drops of our B.3126 extract in 2:1 chloroform/methanol (15.23 g) sample to the silica
plate. We waited for the B.3126 sample to travel up the plate, stopping the run when the solvent
front reached to top of the plate.

LCMS Sample Preparation and GNPS Molecular Networking Computer Processing:

The samples were run on an Agilent LCMS, a 6530C QTOF with a Dual Jet Stream ESI source
and a 1260 binary pump stack using a Phenomenex Gemini column (5µm NX-C18 110 Å 50 x 2
mm) with a gradient elution method. Buffer A was redistilled water with 0.1% formic acid
(puriss. from Sigma-Aldrich), Buffer B was MeOH (Supelco hypergrade for LC-MS from
Millipore) with 0.1% formic acid, and the flow rate was 0.500 mL/min. The starting elution was
80% B, which was held for 2.0 minutes, then the following gradient: a linear increase to 90% B
at 5.0 minutes, then another linear increase to 100 % B at 10.0 minutes which was held for 5.0
minutes, finally then the column was returned to 80% B after 30. seconds and held there to
reequilibrate for 3.0 minutes. Total run time was 18.5 minutes (see Table 1 below).
Table 1: Binary Pump Method
Time (min) A % B%

Flow mL/min Max. Pressure Limit [bar]

0.00

20.0 80.0

0.500

275.00

2.00

20.0 80.0

0.500

275.00

5.00

10.0 90.0

0.500

275.00

10.00

0.0

100.0 0.500

275.00

15.00

0.0

100.0 0.500

275.00

15.50

20.0 80.0

0.500

275.00

18.50

20.0 80.0

0.500

275.00

The sphingolipids method had three-time segments; From the start to 2.0 minutes the flow was
diverted to waste to prevent salts from being sprayed on the mass spectrometer, then from 2.0 to

18.0 minutes the flow was the sent to the mass spectrometer. At the 18-minute mark to the end of
the run it was sent back to waste. Centroid data with an Auto MS/MS method collected in static
positive ion polarity with an absolute storage threshold of 200 and 5 for the MS and MS/MS
scans. The source settings were a drying and sheath gas temperature of 325 and 350 °C
(respectively), drying and sheath gas flow rates of 10 and 12 L/min (respectively), a nebulizer
pressure of 50 psi, and capillary and nozzle voltages of 4000 and 0 V (respectively). The ion
optics settings were the fragmentor at 200 V, the skimmer at 65 V, and the octopole 1 RF Vpp of
750 V.
In the experiment segment from 2.0 to 18.0 minutes the Auto MS/MS settings were: An MS scan
over the mass range of 100-1600 m/z with an acquisition rate of 5 spectra/s with an MS/MS scan
over the mass range of 50-1305 m/z with an acquisition rate of 3 spectra/s. The MS/MS collision
energy was set at a gradient with the following formula: 3(m/z)/100 + 15. For the MS/MS
acquisition, a maximum of 6 precursor per cycle was used, with static exclusion below 250 and
above 1300 m/z, or below an absolute threshold of 10000 counts and active exclusion after 3
spectra within a 0.2 minutes range. Reference mass signals and some common contaminants
were also added to an exclusion list for the entirety of the run (922.0098, 531.40777, 553.38972,
1083.791 m/z at a range of 100 ppm).
In some early runs, the LCMS buffers were made with 5% ammonium formate but these runs
resulted in sphingolipid masses with ppm errors that were far too high to be publishable. Due to
the high ppm error new buffers were remade excluding the use of ammonium formate (as
described above). With our Agilent data I used the msConvert (Proteowizard) program to convert
our data to the .mzXML file format for use on GNPS. Following this we ran the GNPS
molecular networking analysis on our data.

RESULTS AND DISCUSSION
Optimal Media:
In this project I prepared NRRL-1 media, LB media, Brain Heart Infusion (BHI) media,
and the PYG media to determine which media would be best for growth of B-3126. In 15 mL
test tubes we aliquoted separately 5 mL from each medium under sterile conditions. Following
sphingolipid extraction, I used LCMS screening analysis to compare the extracts against known
sphingolipids from the Global Natural Products Social Molecular Networking (GNPS) platform.
5

Quickly identifying candidate ceramides in my samples. The total yield of extract and

abundance of this ceramide mass were compared across the media to identify the best medium
for sphingolipid production. The best medium for sphingolipid production by S. echinoides B3126 following the analysis was NRRL-1.

Salinity Stressor Test:
Through the use of a stressor, in this
case salt (NaCl), the strain S.
echinoides B-3126 might respond by
changing its lipid pool. Despite
hypothesizing that the osmotic stress
caused by the increase in salt
concentration would induce more
sphingolipids, based on following a
ceramide mass through the different extracts, there was not any increase in the production of
sphingolipids. The zero-salt
environment resulted in consistently
higher values in this sphingolipid’s
concentration, leading me to conclude
that the no added salt condition was the
most optimal environment. The results
of this salinity stressor test are
displayed in Figure 1 where the integral
or area under the curve (which is
proportional to the concentration of the
ceramide produced) is plotted against
the salt (NaCl) added in grams.

Figure 2. Structures of the annotated sphingolipids
from B-3126

Sphingolipid Silica Plate Large/Small Scale:
Following the use of Thin-layer chromatography (TLC) through the silica plate I
observed the sample result for Rf values and points of separation. Rf values are as follows:
Total: 3.5 cm, Line to first dot 0.286, line to second dot 0.629. Total grams of final sample
0.0585g. We wanted to see if we could clean the sphingolipids out of the crude extract. We then
tracked the compounds through the TLC and to see if they were any cleaner at the end of it.
The results of the TLC chromatography resulted in sphingolipids separating from other
compounds.

LCMS Sample Analysis and GNPS
Molecular Networking Computer
Processing:
By comparing the library hits recorded
against the GNPS database I was able
to compare our experimental m/z
values from the LC/MS run.
Observing the GNPS library hits (and
molecular formula) for each ceramide,
I was able to calculate the ppm error
of each [M+H] parent mass hit in the
+

Figure 3. Annotation of the fragment masses from
ceramide (18:0/14:0) the 512 m/z parent mass

LC/MS screening.

I was also able to go further and annotate fragment masses within the MS/MS spectra for these
masses, confirming the assignment of these compounds as ceramides (see Figure 2 and 3). By
doing so we were able to confirm the presence of, and characterize the structure of, some of the
sphingolipids in our strain.

FUTURE DIRECTIONS
This project will aid future work to develop a large panel of semi-synthetic sphingolipids that
can be tested in the effort to generate sphingolipids that can trigger specific cytokine types to
function as vaccine adjuvants. Ceramides have a free primary alcohol derived from the serine, in
biology this alcohol can be elaborated with sugar headgroups, as with the CD1d signaling lipid
α-galactosylceramide, using synthetic approaches our lab may be able to append on many other
diverse functional groups with different bioactivities.
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